DXCM flirting with new highs while RSI looks pretty constructive. This looks like it might run a bit so while it might be a nice quick momentum play there is probably a lot of long term appeal here. This also applies to AYX which I just posted.
Symbol DXCM
setup flag
Upcoming Earnings Jan 29, 2019 (EST) Feb 21, 2019 (EST)
Horizontal S&R: yes 138
Channel S&R: no
MA S&R: yes bounced off of 20ma
>200ma: yes
Volume confirmation: ok
Candle Confirmation: yes morning star
Stoch Divergence: no
Reg Trendline >85: no
Short Float: 7%
Entry 152
Stop 137
Price Target 182
Risk / Reward: 1:2
Zacks...
Clearly, that Dec 24 route was the clear buying opportunity, You would've been +40% by now.
Is it too late? I'd say NO.
If you have the ability to invest on this, and of course, have an awareness on all the geopolitical factors. I think this is a win.
If you want to swing, it's also up to you.
Here's the thing
1) Let's be clear, DexCom is the leader on CGM...
DXCM was in our watch list from a while, and it seems its started to move now. If it can breaks its resistance around $50.37 it can go as high as $57 area
* Trade Criteria *
Date First Found- November 6, 2017
Pattern/Why- Fallen angel
Entry Target Criteria- Break of $50.37
Exit Target Criteria- $56.43
Stop Loss Criteria- $47.77
Please check back for Trade...
Recently shares of the Dexcom Inc., that are traded on the NASDAQ exchange, probably have made the bottom and started a new uptrend. Dexcom is a medical device company. The company is focused on development of continuous glucose monitoring systems. Let's look at the price movements of this stock (which is traded at $85.13 now) from the technical point of view....
the stock has cleared in one day a 3 months of downtrend. what a great move only from rumers.
I think we should let the stock pull back up to 83 and then look for an entrance when the potencial is up to 93.
very good for long although the market is going sideway or even will go a bit bearish
sorry about the squiggly, lines - this is my first chart. Anyone agree with what I see? I've been in this one since the low 20s and this company has some killer products and devices in the pipeline as well as 3 pending FDA approvals that will increase the bottom line. I'm
After a strong push to the T/L and slight pullback, buyers stepped in aggressively on Friday. There is not much resistance over 15.60. The first target is the 2011 highs near 17.
